A Study to Evaluate Immune Response Changes to Ovarian Cancer During Chemotherapy


About this study

The study will determine whether the type and number of immune cells (white blood cells) in ovarian cancer tumors after initial chemotherapy impacts ovarian cancer patient outcomes.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Scott Kaufmann, M.D., Ph.D.

Closed for enrollment

Contact information:

Matthew Block M.D., Ph.D.

(507) 293-0553


More information


Publications are currently not available

Mayo Clinic Footer